EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Paracrine regulation of pancreatic cancer cell response to chemotherapy by GLI2–collagen I signaling

Renzo E Vera, Maite G Fernandez-Barrena, Jose M Falero, John Y Kwon, Roberto A Garza, Ashley N Sigafoos, Matthew D Ross, Merih Deniz Toruner, Murat Toruner, Ezequiel J Tolosa, Luciana L Almada, Huocong Huang und 2 weitere

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.110311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Renzo E Vera und 13 weiteren Autor:innen. Beteiligte Einrichtung: Schulze Center for Novel Therapeutics, Division of Oncology Research, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Zinc Finger Protein Gli2, Pancreatic Neoplasms, Collagen Type I, Signal Transduction. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, Mayo Clinic.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the well-described role of noncellular components of the tumor microenvironment (TME) in regulating tumor growth, the molecular events dictating expression and biological functions of key components of the TME remain elusive. Here, using pancreatic cancer (PC) models, we describe a novel mechanism through which the zinc finger transcription factor GLI2 in cancer-associated fibroblasts (CAFs) induces expression of COL1A1, which is a major component of type I collagen, the most abundant collagen variant in the tumor milieu. Bulk and single-nuclei RNA-Seq showed that GLI2 expression in CAF strongly correlates with COL1A1 expression levels, fibrosis, and CAF activation. Chromatin immunoprecipitation-quantitative PCR and expression studies of the PC matrisome identified COL1A1 as the direct target of GLI2 in CAFs. We also provide evidence that GLI2 is an effector that mediates COL1A1 induction by transforming growth factor β1. RNA-Seq analysis of PC cells treated with type I collagen revealed enrichment of chemotherapeutic gene expression profiles, which includes irinotecan resistance signature. Viability studies confirmed that type I collagen promotes irinotecan resistance in PC cells. Altogether, our results uncover a novel role for the transforming growth factor β1-GLI2 axis within CAFs to modulate type I collagen expression and promote chemoresistance in PC cells. Together, our findings help increase the understanding of the complex molecular network operating in the TME.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Zinc Finger Protein Gli2Pancreatic NeoplasmsCollagen Type ISignal TransductionParacrine CommunicationHumansCollagen Type I, alpha 1 ChainCell Line, TumorGene Expression Regulation, NeoplasticCancer-Associated FibroblastsDrug Resistance, NeoplasmTumor MicroenvironmentIrinotecanTransforming Growth Factor beta1Nuclear Proteins

Stichwörter der Autor:innen

GLI2collagenfibroblastpancreatic cancertumor microenvironment

Substanzen

Zinc Finger Protein Gli2Collagen Type IGLI2 protein, humanCollagen Type I, alpha 1 ChainCOL1A1 protein, humanIrinotecanTransforming Growth Factor beta1Nuclear Proteins

Autor:innen und Institutionen

  • Schulze Center for Novel Therapeutics, Division of Oncology Research, Rochester, Minnesota, USA.
  • Department of Surgery, Hamon Center for Therapeutic Oncology Research, UT Southwestern, Dallas, Texas, USA; Department of Immunology, Hamon Center for Therapeutic Oncology Research, UT Southwestern, Dallas, Texas, USA.
  • Department of Surgery, Hamon Center for Therapeutic Oncology Research, UT Southwestern, Dallas, Texas, USA; Department of Pharmacology, Hamon Center for Therapeutic Oncology Research, UT Southwestern, Dallas, Texas, USA.
  • Schulze Center for Novel Therapeutics, Division of Oncology Research, Rochester, Minnesota, USA. Electronic address: FernandezZapico.Martin@mayo.edu.

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • Mayo Clinic
  • National Institutes of Health National Cancer Institute

Zitieren

APA

Vera, R. E., Fernandez-Barrena, M. G., Falero, J. M., Kwon, J. Y., Garza, R. A., Sigafoos, A. N., Ross, M. D., Toruner, M. D., Toruner, M., Tolosa, E. J., Almada, L. L., Huang, H., Brekken, R. A., & Fernandez-Zapico, M. E. (2025). Paracrine regulation of pancreatic cancer cell response to chemotherapy by GLI2–collagen I signaling. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110311

Vancouver

Vera RE, Fernandez-Barrena MG, Falero JM, Kwon JY, Garza RA, Sigafoos AN, et al. Paracrine regulation of pancreatic cancer cell response to chemotherapy by GLI2–collagen I signaling. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110311

BibTeX
@article{Vera2025,
  author = {Vera, Renzo E and Fernandez-Barrena, Maite G and Falero, Jose M and Kwon, John Y and Garza, Roberto A and Sigafoos, Ashley N and Ross, Matthew D and Toruner, Merih Deniz and Toruner, Murat and Tolosa, Ezequiel J and Almada, Luciana L and Huang, Huocong and Brekken, Rolf A and Fernandez-Zapico, Martín E},
  title = {Paracrine regulation of pancreatic cancer cell response to chemotherapy by GLI2–collagen I signaling},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.110311}
}
Kostenlos starten →